High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma withMYCN amplification-Reference-Cited by-同舟云学术

High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma withMYCN amplification

Published:2004-08-18 Issue:5 Volume:101 Page:1081-1089
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Laprie Anne,Michon Jean,Hartmann Olivier,Munzer Caroline,Leclair Marc-David,Coze Carole,Valteau-Couanet Dominique,Plantaz Dominique,Carrie Christian,Habrand Jean-Louis,Bergeron Christophe,Chastagner Pascal,Défachelles Anne-Sophie,Delattre Olivier,Combaret Valérie,Bénard Jean,Pérel Yves,Gandemer Virginie,Rubie Hervé,

Publisher

Wiley

Subject

Cancer Research,Oncology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dinutuximab-beta after autologous peripheral blood stem cell transplantation improved event-free survival of newly diagnosed children with high-risk neuroblastoma but overall survival remains unchanged: Saudi Arabia's multi-institutional experiences;European Journal of Oncology Pharmacy;2024-07

2. Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy;Cancers;2024-04-29

3. Computed tomography-based radiomics to assess risk stratification in pediatric malignant peripheral neuroblastic tumors;Medicine;2023-11-24

4. Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and withoutMYCNAmplification: A Children's Oncology Group (COG) Report;Clinical Cancer Research;2023-02-07

5. Les essais qui changent les pratiques : le point en 2022;Cancer/Radiothérapie;2022-10